West Pharmaceutical Services company profile
Company profile
West Pharmaceutical Services has 10,000 employees and is headquartered in Exton, United States.
Biologic, generic and pharmaceutical drug companies are the main customers for the packaging and delivery systems, while pharmaceutical, diagnostic and medical device companies order contract-manufactured devices. Sales reach the Americas, Europe, the Middle East, Africa and Asia Pacific through its sales force, contract sales agents and regional distributors. Product lines include stoppers and seals, syringe and cartridge parts, vials, self-injection devices and administration systems for reconstitution and mixing, along with inspection, sterilization and analytical lab services.
In the fiscal year ended December 2025, revenue reached 3.1 billion USD, up 6.3% from the prior year, and net income was 493.7 million USD. The United States generated 43.3% of revenue, followed by other European countries at 14.7%, Germany at 12.4%, other countries at 11.5%, Ireland at 10.8% and France at 7.4%. The company, founded in 1923, had 10,000 employees and is headquartered in Exton, Pennsylvania.
Company facts
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Headquarters
- 530 Herman O. West Drive, 19341-1147, Exton
- Employees
- 10,000
- Chief executive
- Michel Lagarde
- Founded
- 1923
- Fiscal year
- January - December
- Listing
- WST · NYSE
- Indices
- S&P 500
- Currency
- USD
- ISIN
- US9553061055
- Website
- westpharma.com
West Pharmaceutical Services and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| West Pharmaceutical ServicesWST | United States | $29.1B | 10,000 | 22.9% | 46.9 |
| ResMedRMD | United States | $33.5B | 11,370 | 34.0% | 21.8 |
| MedlineMDLN | United States | $42.57B | 45,000 | 5.0% | 40.2 |
| SolventumSOLV | United States | $15.07B | 20,584 | 5.9% | 99.6 |
| Becton, DickinsonBDX | United States | $58.96B | 60,000 | 15.7% | 42.8 |
| Baxter InternationalBAX | United States | $13.41B | 37,500 | 7.6% | — |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
